The efficacy of wrist working splints in patients with non-destructive wrist arthritis

ISRCTN ISRCTN22172654
DOI https://doi.org/10.1186/ISRCTN22172654
Secondary identifying numbers NL586 (NTR642)
Submission date
28/04/2006
Registration date
28/04/2006
Last edited
23/09/2021
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Not provided at time of registration

Contact information

Dr M.M. Veehof
Scientific

University Twente
Department of Psychology and Communication of Health and Risk
P.O. Box 217
Enschede
7500 AE
Netherlands

Phone +31 (0)53 4892939
Email m.m.veehof@utwente.nl

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific titleThe efficacy of wrist working splints in patients with non-destructive wrist arthritis
Study hypothesisWe expect a reduction of pain in the wrist, measured with a Visual Analogue Scale (VAS), after 4 weeks of wrist working splint wearing, and a difference in pain score between the experimental group (splinting intervention as adjuvant to usual treatment) and the control group (usual treatment).
Ethics approval(s)Ethics approval received from the local medical ethics committee
ConditionRheumatoid arthritis, arthritis of the wrist
InterventionPatients are randomly allocated to the experimental group (splinting intervention as adjuvant to usual treatment) or the control group (usual treatment). Patients in the experimental group receive a wrist working splint for their most painful hand. The splint is fitted by an occupational therapist who also gives education on splint wearing. To optimize compliance with splint wearing, compliance enhancing measures are included in this education. Patients are asked to wear the splint by day as much as possible (especially during activities) for four weeks.
Intervention typeOther
Primary outcome measurePatients are measured twice: at baseline and after 4 weeks.

Primary outcome measure is pain in the wrist (VAS 0-100 mm).
Secondary outcome measures1. Pain in the wrist (box scale 0-10)
2. Number of painful and swollen joints in the hand (joint count max score 11 and Ritchie scale max score 33)
3. Synovitis (ultrasound)
4. Grip strength
5. Dexterity (SODA, DASH)
6. Patient's subjective judgement about the effect of the splint on pain, swelling, grip strength and hand function
Overall study start date22/11/2005
Overall study end date01/10/2006

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants60
Participant inclusion criteria1. Diagnosis of RA according to the 1987 ACR criteria
2. Stable disease modifying anti-rheumatic drug (DMARD) therapy during preceding 3 months and no change expected for the next 4 weeks
3. Stable symptomatic therapy (non-steroidal anti-inflammatory drugs [NSAIDs] and corticosteroids) during preceding 2 weeks and no change expected for the next 4 weeks
4. Active arthritis of the wrist due to RA (clinical judgement rheumatologist)
5. Painful wrist over the past 24 hours (VAS score >35 mm)
6. Age >17 years
Participant exclusion criteria1. Unable to wear a wrist splint (due to a rash, allergies etc.)
2. An injection of corticosteroid medication in the wrist or any small joints of the hand or flexor tendon sheath of the hand within the preceding 1 month or the expectation that such an injection will be indicated in the next 4 weeks
3. Carpal tunnel syndrome
4. Deformities of wrist (any [sub]luxation, any deviation) and/or fingers (e.g. MCP ulnar drifts, swan neck deformities, boutonniere deformities, subluxations thumb)
5. History of jint surgery of the wrist
6. Use of a wrist orthesis during the 2 weeks prior to participation in the study
7. Steinbrocker functional classification of 4
8. Difficulties with the Dutch language
Recruitment start date22/11/2005
Recruitment end date01/10/2006

Locations

Countries of recruitment

  • Netherlands

Study participating centre

University Twente
Enschede
7500 AE
Netherlands

Sponsor information

University of Twente, Department of Psychology and Communication of Health and Risk (PCGR) (The Netherlands)
University/education

P.O. Box 217
Enschede
7500 AE
Netherlands

ROR logo "ROR" https://ror.org/006hf6230

Funders

Funder type

Research organisation

Stichting ReumaOnderzoek Twente (The Netherlands)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

23/09/2021: Proactive update review. No publications found. Search options exhausted.